header logo image

Aquestive Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

August 7th, 2024 2:40 am

WARREN, N.J., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, reported financial results for the second quarter, which ended June 30, 2024, and provided an update on recent developments in its business.

See more here:
Aquestive Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick